Advanced Micro Devices shares slumped on Tuesday after the chipmaker forecast quarterly sales below estimates due to a weak PC market, overshadowing the company's optimism that the chip market would start to recover in the second half of 2023.
The logo of semiconductor company Advanced Micro Devices Inc is seen on a graphics processing unit chip in this illustration picture taken February 17, 2023. REUTERS/Florence Lo/Illustration/File Photoshares slumped on Tuesday after the chipmaker forecast quarterly sales below estimates due to a weak PC market, overshadowing the company's optimism that the chip market would start to recover in the second half of 2023.
While analysts had watched AMD grab market share in the data center after Intel delayed ramping up the shipping of its most powerful data center processor chip code, named Sapphire Rapids, for over a year, some said they were seeing AMD now stall. Still, AMD CEO Lisa Su told investors on a conference call that the first quarter was the bottom of the market for the company's PC business and the industry.Part of that growth, Su said, will come from a chip called the MI300, which will compete with Nvidia Corp's"We do believe that we will start ramping revenue in the fourth quarter with cloud AI customers, and then it'll be more meaningful in 2024," Su said.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
AMD faces doubts after Intel earnings: Is the bar set too high?Advanced Micro Devices Inc. won't have the dismally low expectations that Intel Corp. had to clear last week when it reports its results.
Weiterlesen »
AMD forecasts second quarter below estimates with slow chip demandAdvanced Micro Devices forecast second-quarter revenue below estimates on Tuesday, showing the chip firms will continue to face challenges as PC sales and the data center market remain weak.
Weiterlesen »
Uncontrolled Wet AMD: Drug Switch Can Mute Disease ActivitySome patients with uncontrolled neovascular age-related macular degeneration achieved a reduction in disease activity and gains in visual acuity after switching to the biologic agent brolucizumab, according to a new study presented ARVO2023. nAMD
Weiterlesen »
Symptom Severity Linked to Risk for Death in Advanced CancerIdentifying older patients with advanced cancer who have a high risk for hospitalization and death could be a game changer. A new analysis suggests that goal is within reach. OncTwitter
Weiterlesen »
Opinion: King Lear, Joe Biden and running the place at an advanced ageKing Lear had a terrible time in old age, but at least he did not have to run for re-election. President Joe Biden officially, as of last week, has no such luxury.
Weiterlesen »